Private Equity

PE Fund Investments

Cardiac stents maker Integris Health raises funding from India SME Fund, others

Entrackr   Translumina Therapeutics  

New Delhi-based, Everstone Capital-backed Integris Health which manufactures cardiac stents under the brand Translumina Therapeutics has raised primary capital from a consortium of investors, including Mukul Agarwal and India SME Fund.The fresh capital will be used for the company's expansion into multiple therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and in-house product development initiatives. The firm is looking to list by the end of 2025.Founded in 2008 by Gurmit Singh Chugh, Integris Health has a presence in interventional cardiology, cardiovascular, and vascular surgery areas.

In August 2019, Everstone Capital acquired 60% stake in Translumina Therapeutics for USD 79 M and later in June 2024 it had merged the company with Singapore-based Everlife Holdings.